UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 253

Sortiert nach

Quality Improvement Guidelines for Bone Tumour Management

Cardiovascular and interventional radiology, 2010-08, Vol.33 (4), p.706-713

2010

Volltextzugriff (PDF)

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

Annals of oncology, 2011-05, Vol.22 (5), p.1154-1163

2011

Volltextzugriff (PDF)

Vaccines for the treatment of non-small cell lung cancer

Revue des maladies respiratoires, 2019-03, Vol.36 (3), p.415

2019

Volltextzugriff (PDF)

MTE09.01 Evidence Based Management of the Patient over 80

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S215-S216

Quoix, E.

2018

Volltextzugriff (PDF)

Platinum drugs in the treatment of non-small-cell lung cancer

British journal of cancer, 2002-10, Vol.87 (8), p.825-833

2002

Volltextzugriff (PDF)

Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2002-01, Vol.20 (1), p.247-253

Depierre, A.

2002

Volltextzugriff (PDF)

Maintenance chemotherapy versus follow-up after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): IFCT-1201 MODEL randomised phase III trial

Annals of oncology, 2018-10, Vol.29, p.viii744-viii745

2018

Volltextzugriff (PDF)

3054 Health-related quality of life in elderly patients with advanced non-small-cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy in the Phase 3 IFCT-0501 trial

European journal of cancer (1990), 2015-09, Vol.51, p.S613-S614

2015

Volltextzugriff (PDF)

Epidemiological novelties in lung cancer

Revue des maladies respiratoires, 2011-10, Vol.28 (8), p.1048

2011

Volltextzugriff (PDF)

Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report

Cancer radiothérapie, 2015-05, Vol.19 (3), p.192-197

2015

Volltextzugriff (PDF)

3128 EGFR, ALK, KRAS prognostic value in a large French prospective cohort of non-previously treated advanced NSCLC. Preliminary report of the IFCT-PREDICT.amm cohort

European journal of cancer (1990), 2015-09, Vol.51, p.S646-S646

2015

Volltextzugriff (PDF)

Novel epidemiology in lung cancer - non-smokers, women and cannabis

Revue des maladies respiratoires, 2007-10, Vol.24 (8 Pt 2), p.6S10

Quoix, E

2007

Volltextzugriff (PDF)

EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up

The European respiratory journal, 2009-02, Vol.33 (2), p.436-440

2009

Volltextzugriff (PDF)

EP-1150 Superior sulcus non small cell lung carcinoma: Retrospective analysis of 42 patients

Radiotherapy and oncology, 2014, Vol.111, p.S37-S37

2014

Volltextzugriff (PDF)

TIME, a Phase 2b/3 Study Evaluating TG4010 in Combination With First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Phase 2b Results

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S35-S35

2014

Volltextzugriff (PDF)

Safety culture assessment in a university pulmonary medicine department

Revue des maladies respiratoires, 2015-09, Vol.32 (7), p.715

2015

Volltextzugriff (PDF)

Non-small cell lung cancer in the elderly. What chemotherapy?

Revue des maladies respiratoires, 2006-11, Vol.23 (5 Pt 3), p.16S95

Quoix, E

2006

Volltextzugriff (PDF)

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

The Lancet (British edition), 1993-07, Vol.342 (8862), p.19-21

1993

Volltextzugriff (PDF)

1827P European Society for Medical Oncology (ESMO)/International Society of Geriatric Oncology (SIOG) Joint Working Group (WG) survey on management of older patients with cancer

Annals of oncology, 2021-09, Vol.32, p.S1237-S1238

2021

Volltextzugriff (PDF)

Chemotherapy in Addition to Supportive Care Improves Survival in Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 16 Randomized Controlled Trials

Journal of clinical oncology, 2008-10, Vol.26 (28), p.4617-4625

2008

Volltextzugriff (PDF)

Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française

Revue des maladies respiratoires, 2014-01, Vol.31 (1), p.91

2014

Volltextzugriff (PDF)

Management and outcome of French elderly patients with lung cancer: an IFCT survey

Revue des maladies respiratoires, 2010-05, Vol.27 (5), p.421

2010

Volltextzugriff (PDF)

1019P Pattern of clinical activity of anticancer vaccine OSE2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO) in phase III Atalante-1 randomized trial

Annals of oncology, 2022-09, Vol.33, p.S1020

2022

Volltextzugriff (PDF)

1024P Net treatment benefit of OSE2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO) in phase III Atalante-1 randomized trial

Annals of oncology, 2022-09, Vol.33, p.S1022-S1023

2022

Volltextzugriff (PDF)

1260MO Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (ICI): Step 1 results of phase III ATALANTE-1 randomised trial

Annals of oncology, 2020-09, Vol.31, p.S814-S815

2020

Volltextzugriff (PDF)

1 – 25 von 253

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(206)
Mit Volltextzugriff
(208)

Publikationsform

Artikel
(252)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(87)
Life Sciences & Biomedicine
(55)
Science & Technology
(55)
Biological And Medical Sciences
(30)
Male
(30)
Medical Sciences
(29)
Respiratory System
(29)
Lung Neoplasms - Drug Therapy
(28)
Oncology
(26)
Female
(23)
Aged
(21)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(20)
Sciences Biologiques Et Medicales
(19)
Sciences Medicales
(19)
Lung Cancer
(18)
Lung Neoplasms - Therapy
(18)
Chemotherapy
(17)
Lung Neoplasms - Pathology
(17)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(16)
Pharmacology. Drug Treatments
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quality Improvement Guidelines for Bone Tumour Management

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

Vaccines for the treatment of non-small cell lung cancer

MTE09.01 Evidence Based Management of the Patient over 80

Platinum drugs in the treatment of non-small-cell lung cancer

Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non–Small-Cell Lung Cancer

Maintenance chemotherapy versus follow-up after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): IFCT-1201 MODEL randomised phase III trial

3054 Health-related quality of life in elderly patients with advanced non-small-cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy in the Phase 3 IFCT-0501 trial

Epidemiological novelties in lung cancer

Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report

3128 EGFR, ALK, KRAS prognostic value in a large French prospective cohort of non-previously treated advanced NSCLC. Preliminary report of the IFCT-PREDICT.amm cohort

Novel epidemiology in lung cancer - non-smokers, women and cannabis

EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up

EP-1150 Superior sulcus non small cell lung carcinoma: Retrospective analysis of 42 patients

TIME, a Phase 2b/3 Study Evaluating TG4010 in Combination With First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Phase 2b Results

Safety culture assessment in a university pulmonary medicine department

Non-small cell lung cancer in the elderly. What chemotherapy?

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

1827P European Society for Medical Oncology (ESMO)/International Society of Geriatric Oncology (SIOG) Joint Working Group (WG) survey on management of older patients with cancer

Chemotherapy in Addition to Supportive Care Improves Survival in Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 16 Randomized Controlled Trials

Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française

Management and outcome of French elderly patients with lung cancer: an IFCT survey

1019P Pattern of clinical activity of anticancer vaccine OSE2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO) in phase III Atalante-1 randomized trial

1024P Net treatment benefit of OSE2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO) in phase III Atalante-1 randomized trial

1260MO Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (ICI): Step 1 results of phase III ATALANTE-1 randomised trial

Aktive Filter

Suchergebnisse filtern